Bio-Techne Corp Shares Outstanding 2010-2024 | TECH

Bio-Techne Corp shares outstanding for the quarter ending September 30, 2024 were 0.161B, a 0.51% decline year-over-year.

  • Bio-Techne Corp 2024 shares outstanding were 0.161B, a 0.67% decline from 2023.
  • Bio-Techne Corp 2023 shares outstanding were 0.162B, a 1.38% decline from 2022.
  • Bio-Techne Corp 2022 shares outstanding were 0.164B, a 1.35% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Bio-Techne Corp Shares Outstanding 2010-2024 | TECH

  • Bio-Techne Corp 2024 shares outstanding were 0.161B, a 0.67% decline from 2023.
  • Bio-Techne Corp 2023 shares outstanding were 0.162B, a 1.38% decline from 2022.
  • Bio-Techne Corp 2022 shares outstanding were 0.164B, a 1.35% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$150.5B
Bristol Myers Squibb (BMY)$118.1B
Vertex Pharmaceuticals (VRTX)$115.4B
Gilead Sciences (GILD)$109.4B
CSL (CSLLY)$85.4B
Regeneron Pharmaceuticals (REGN)$81.8B
GSK (GSK)$69.3B
Argenex SE (ARGX)$34.4B
Alnylam Pharmaceuticals (ALNY)$30.2B
BioNTech SE (BNTX)$25.5B
Biogen (BIIB)$22.6B
Illumina (ILMN)$21.4B
BeiGene (BGNE)$18.3B
Moderna (MRNA)$14.3B
Incyte (INCY)$13.6B
Genmab (GMAB)$13.6B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$11.8B
Vaxcyte (PCVX)$10.9B
Sarepta Therapeutics (SRPT)$10.2B
Exact Sciences (EXAS)$10B
Exelixis (EXEL)$9.8B
Revolution Medicines (RVMD)$9.5B
Bio-Rad Laboratories (BIO.B)$9.4B
QIAGEN (QGEN)$9.3B
Intra-Cellular Therapies (ITCI)$8.8B
Roivant Sciences (ROIV)$8.4B
Ascendis Pharma (ASND)$7.5B
Repligen (RGEN)$7.2B
Legend Biotech (LEGN)$7B